Your browser version is outdated. We recommend that you update your browser to the latest version.

Silujin enters into JV partnership with Beta Drugs Limited, India

Posted 9/10/2018

Tashkent, Uzbekistan - Silujin LLC today entered into a JV partnership agreement with Beta Drugs Limited, leading Indian oncology formulations manufacturing company. Companies formed a partnership to develop, manufacture and market injectables and orals formulations in Uzbekistan. The manufacturing facility for orals formulations will be located in Bekabad city of Tashkent province that will fully conform the GMP standards. To note, this facility will be first ever facility to manufacture and market oncology formulations in Uzbekistan.

Read the rest of this entry »